New findings—COVID-19 aftereffects may be due to membranous inflammation?

The following article is nothing more than an impression of one practitioner in Japan, and there is no scientific basis yet. However, I have experienced with 52 confirmed cases and 189 suspicious cases of COVID-19 aftereffects.

There are wide-ranging symptoms of COVID-19 aftereffects. Common symptoms include slight fever, headache, malaise, coldness, numbness, muscular pain, joint pain, eczema, diarrhea, loss of appetite, palpitation, respiratory distress, taste and olfactory dysfunctions, and sleeplessness. Recently, hair loss has also been reported.

I have been thinking that COVID-19 tends to cause inflammation of the diaphragm, pleura, and pericardium, which can eventually lead to respiratory distress, palpitation, and loss of appetite. Headaches, coldness, and poor thermoregulation may also be caused by inflammation of the dura mater and pia mater. Furthermore, I have diagnosed relatively many cases of olfactory dysfunctions as parosmia, which were possibly due to inflammation of the brain membrane. It seems that the sense of smell is more susceptible to damage because of the large area of contact between the brain membrane and the olfactory bulb. It also makes sense when considering diarrhea and muscle pain as inflammation of the mesentery and fascia.

Given all these factors, I conclude at this time that COVID-19 aftereffects are the systemic membranous inflammation. I am treating this with Japanese Kampo medicine.


Some people may feel it odd to include the diaphragm because it is an only muscle. However, the diaphragm has relatively large fascia to muscle mass and is in contact with various fasciae, pleura, and pericardium, so I think this could cause the same that inflammation as in other membranous structures.